Mounjaro and TRT: what men on testosterone replacement therapy should know

TRT and Mounjaro are not known to be directly contraindicated, but both affect body composition and hormone balance — a prescriber must assess the combination for your individual situation.
Significant weight loss (which tirzepatide can produce) may itself raise endogenous testosterone in men with obesity, which can affect how a TRT dose is calibrated over time.
Mounjaro slows gastric emptying, which primarily matters for oral medicines — injectable testosterone and topical gels are not absorbed through the gut and are unaffected by this mechanism.
Any change in how you feel on TRT after starting Mounjaro (energy, mood, libido, haematocrit) is worth flagging promptly to the clinician managing your testosterone therapy.

If you are taking testosterone replacement therapy and considering Mounjaro for weight management, the most important thing to know upfront is this: there is currently no direct clinical trial evidence showing that tirzepatide interacts adversely with TRT, but both treatments affect hormone physiology in overlapping ways, and your prescriber needs to know about every medicine you take. Mounjaro is a prescription-only medicine licensed for weight management in adults with a BMI of 30 or above, or 27 or above with a weight-related condition. Starting it alongside TRT requires a full clinical review, not a quick tick-box.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How Mounjaro and TRT interact in practice, and what to watch for

Does Mounjaro interfere with how TRT works in the body?

The short answer is: not directly, in the pharmacological sense. Tirzepatide (the active ingredient in Mounjaro) works on GIP and GLP-1 receptors involved in appetite regulation and glucose control. Testosterone, whether injected, applied as a gel, or delivered via patch, enters the bloodstream through a completely different route. Because Mounjaro's well-documented effect on gastric emptying applies to things passing through the gut, it does not slow the absorption of injectable testosterone (such as Sustanon or Nebido) or topical preparations at all.

Where the two therapies genuinely do intersect is in their downstream effects on body composition. Mounjaro produces substantial fat loss in many people; the SURMOUNT-1 trial, published in the New England Journal of Medicine, recorded average weight reductions of around 20% over 72 weeks at the highest dose. Fat tissue is itself a site of oestrogen production and testosterone conversion, so losing a significant amount of it changes the hormonal environment. Men who have been stable on a TRT dose for years may find that their clinical picture shifts as their body composition changes, not because the medicines clash, but because the biology moves beneath both of them. Your TRT prescriber should be aware that you are starting tirzepatide, and the dose of testosterone you need may warrant re-evaluation once meaningful weight loss has occurred.

This is also the reason some men notice changes in libido, energy or mood during the weight-loss phase of treatment that can be tricky to attribute cleanly. It is worth keeping both prescribers in the loop rather than adjusting anything unilaterally. Mounjaro and erectile dysfunction covers some of the overlapping questions men raise about sexual health on treatment.

Can low testosterone make weight loss harder, and does Mounjaro help with that?

Yes, low testosterone is associated with reduced lean muscle mass, increased visceral fat, and lower energy levels, all of which make sustained weight loss more difficult. TRT can help correct this, and many men find that being on an optimised testosterone level makes diet and exercise changes more effective. Mounjaro addresses weight through a different lever: reducing appetite and slowing caloric intake rather than directly altering hormone levels. Used alongside an appropriately managed TRT regimen, the two can work in the same direction, supporting body composition improvement from different angles.

What tirzepatide does not do is compensate for undiagnosed or undertreated hypogonadism. If fatigue, poor muscle recovery, mood changes or unexplained weight gain are primarily driven by low testosterone, treating the testosterone deficiency is the clinical priority. Mounjaro is licensed for weight management alongside a reduced-calorie diet and increased physical activity, it is part of a broader plan, not a replacement for addressing the underlying hormonal picture. The Mounjaro treatment overview explains the licensed indication in more detail.

Men on TRT who are also carrying significant excess weight may meet the eligibility criteria for tirzepatide. A BMI of 30 or above, or 27 or above with a condition such as type 2 diabetes, hypertension or dyslipidaemia, generally brings someone into scope. The prescriber assesses the full picture (current medications, comorbidities, and clinical history) before any treatment is approved.

Are there any monitoring points specific to this combination?

A few are worth knowing about. Haematocrit (the proportion of red blood cells in the blood) is already a standard monitoring point for men on TRT, since testosterone can raise it; men losing a substantial amount of weight may see shifts in blood volume and concentration that merit an updated check. This is not a reason to avoid the combination, but a reason to stay current with the bloods your TRT prescriber has already arranged.

Mounjaro carries a Black Triangle (▼) designation with the MHRA, meaning it is subject to additional monitoring as a relatively new medicine. You can read the NHS patient information for tirzepatide for a plain-English overview of what to watch for. Common side effects are predominantly gastrointestinal (nausea, diarrhoea, constipation, reflux) most noticeable at the start of treatment or after a dose step up, and they tend to settle as the body adjusts. These are not unique to men on TRT, but if persistent vomiting is affecting your ability to eat adequately, that can affect muscle mass and should be flagged quickly.

Men taking oral medicines alongside either treatment should raise that with their prescriber. For tirzepatide specifically, the NHS England guidance on weight-management injections notes that the oral contraceptive pill's absorption may be affected, and the same reasoning applies in principle to any time-critical oral medicine. If you take an oral testosterone preparation rather than an injection or gel (which is less common in the UK) this is a specific question worth raising. Some men also ask whether Mounjaro affects their ears or hearing as they lose weight, and our page on Mounjaro and clogged ears addresses what is known about that. Tirzepatide's broader interaction with hormone-related treatments is covered in our pages on tirzepatide and TRT and Mounjaro and HRT.

What happens practically when you order Mounjaro through a regulated UK pharmacy?

Every order through a regulated service starts with a clinical consultation. At nume, a GPhC-registered Independent Prescriber reads your medical history (including your current medications) before any approval decision is made. A prescriber, not software, makes that call. You will be asked about TRT: what you are taking, how it is administered, and who manages it. Disclosing this is in your interest; it is how the prescriber determines whether Mounjaro is appropriate and flags anything your TRT clinician should know.

If approved, your Mounjaro KwikPen arrives the next working day via DPD, in plain unbranded packaging, with a tracking notification to your phone. The pen contains four weekly doses, pre-filled and ready to use following the instructions in the leaflet. The pharmacy you use should be verifiable on the GPhC register at pharmacyregulation.org. Fake pens are a real risk when medicines are sold online without a prescription, the MHRA has warned publicly about counterfeit weight-loss injections and made large seizures of them across the UK. Price questions about private treatment are covered honestly on the Mounjaro price context page. If you have other questions about how our service works, our about page sets it out plainly. Speak to our prescribers through a free consultation if you want an assessment that takes your TRT into account from the start.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions